Background: hypoxia-inducible factor (HIF1A) regulates the myocardial response to hypoxia and hemodynamic load. We investigated the association of HIF1A variants with right-ventricular (RV) remodeling after tetralogy of Fallot (TOF) repair. Methods: children with TOF were genotyped for three single-nucleotide polymorphisms in HIF1A. Genotypes were analyzed for association with RV myocardial protein expression and fibrosis at complete repair (n = 42) and RV dilation, fractional area change, and freedom from pulmonary valve/conduit replacement on follow-up. results: In 180 TOF patients, mean age at repair was 1.0 ± 0.8 y with follow-up at 9.0 ± 3.5 y; 82% had moderate to severe pulmonary insufficiency. Freedom from RV reinterventions at 5, 10, and 15 y was 92, 84, and 67%, respectively. Patients with more functioning HIF1A alleles had higher transforming growth factor β1 expression and more fibrosis at initial repair as compared with controls (P < 0.05). During follow-up, patients with more functioning HIF1A alleles showed less RV dilation, better preservation of RV function, and greater freedom from RV reinterventions (P < 0.05). This was confirmed in a replication cohort of 69 patients. conclusion: In children who have had TOF repair, a lower number of functioning HIF1A alleles was associated with RV dilation and dysfunction, suggesting that hypoxia adaptation in unrepaired TOF may influence RV phenotype after repair.
t etralogy of Fallot (TOF) is the most common cyanotic congenital heart defect, occurring in 4 of every 10,000 births (1). "Classic" TOF comprises pulmonary stenosis, ventricular septal defect, aortic override, and right-ventricular (RV) hypertrophy. In the unrepaired state, the right ventricle is exposed to hypoxia and pressure overload. Even after complete surgical repair (typically performed in early infancy), persistent pulmonary regurgitation after repair is common and contributes to progressive RV dilation often culminating in RV failure, ventricular arrhythmias, and reduced survival (2). Recent attempts at preserving pulmonary valve function at primary repair have not translated into long-term benefits on RV dilation and dysfunction (3, 4) . Similarly, pulmonary valve replacement after the onset of RV dilation facilitates reverse RV remodeling but does not restore normal ventricular function and exercise capacity (5) . Therefore, the strategy of relying on RV dilation as a primary indication for reintervention has met with limited success. In order to identify at-risk patients early, before significant RV modeling has occurred, requires a better understanding of the genes and biologic pathways that mediate RV remodeling.
One such pathway is the hypoxia-response pathway, which is activated in response to both hypoxia and mechanical or hemodynamic stress. The right ventricle is exposed to chronic hypoxia and pressure overload during fetal life and infancy before TOF repair, and to ongoing hemodynamic stresses related to volume overload from pulmonary insufficiency and/or pressure overload from conduit stenosis after TOF repair. A central mediator of cardiac adaptation to hypoxia and mechanical stress is hypoxia-inducible factor 1α (HIF1A). In acute hypoxia, HIF1A is cardioprotective by virtue of its ability to induce angiogenic, metabolic, and erythropoietic genes (6, 7) . Chronic HIF1A upregulation however can promote transforming growth factor β1 (TGFβ1)-mediated organ fibrosis (8, 9) . TGFβ1 promotes the transformation of endothelial and smooth muscle cells to fibroblasts. With ongoing stress, fibroblasts convert to proliferating myofibroblasts that induce extracellular matrix deposition and fibrosis. This mechanism for cardiac fibrosis was first reported by Zeisberg et al. (9) in mouse hearts in response to pressure overload. Importantly, this process of fibroblast transformation was reversible by TGFβ1 inhibition. The process of active fibroblast transformation may therefore reflect a reversible protective response to environmental stress that facilitates the transition of stressed endothelial or smooth muscle cells into fibroblasts to help them survive in adverse environmental conditions. These processes have not been evaluated in TOF, in which the right ventricle is exposed to chronic hypoxia and hemodynamic stresses. Our previous study showed that several TOF patients with severe hypoxia showed impaired RV adaptation, with downregulation of vascular endothelial growth factor (VEGF) and antioxidant enzymes and upregulation of collagen and plasma lactate levels postoperatively (10) . However, the cause of Articles Jeewa et al.
impaired myocardial adaptation to hypoxia in some patients and the long-term impact of chronic hypoxia on RV remodeling were not studied.
The purpose of this study was to evaluate the influence of genetic variations in HIF1A on RV angiogenic factor expression and fibrosis at the time of surgical repair in infancy and on RV remodeling during serial follow-up after surgery. Specifically, we investigated the association of three common variants in the HIF1A gene with RV fibrosis at the time of complete repair and on RV size, RV function, and freedom for RV reinterventions during follow-up.
RESuLTS

Primary Cohort
One hundred and eighty eligible patients were included; 55% were male. Clinical and echocardiographic characteristics are described in Table 1 . Median age at repair was 0.6 y, mean age at follow-up was 9 y, 84% had "classic" TOF, and 82% had moderate to severe pulmonary regurgitation at last follow-up.
HIF1A Allele Frequencies
Frequencies of functioning HIF1A alleles were: HIF1A145T 74%, HIF1A1326C 82%, and HIF1A1744C 89%. Cumulative frequencies were as follows: 1% of the cohort had one, 2% had two, 16% had three, 15% had four, 14% had five, and 51% had six functioning alleles. Genotype frequencies were comparable with the ventricular septal defects controls as well as the general population (data not shown). All genotypes were in Hardy-Weinberg equilibrium with no gender-based differences in single-nucleotide polymorphism (SNP) frequencies. Whites had a higher frequency of functioning alleles as compared with non-whites (92 vs. 74%, P = 0.01). The analysis was therefore adjusted for race to address racial differences in SNP frequencies. There were no associations between year of birth and frequency of high-risk alleles (P = 0.11). Analysis was also adjusted for TOF subtype, age at surgery, year of primary repair, type of repair, and duration of follow-up.
HIF1A Genotype and RV Phenotype Associations
A higher number of functioning HIF1A alleles was associated with lower RV outflow tract z-scores at last follow-up (estimated effect size (EST): −0.365(0.118)z per functioning allele, P = 0.002) (Figure 1a) , slower progression of pulmonary valve regurgitation (EST: +0.015/y 2 for zero to three functioning alleles, +0.009/y 2 for four or five functioning alleles and 0.006/y 2 for six functioning alleles, P = 0.005), and slower progression of RV dilation over time (EST: +0.021/y 2 for zero to three functioning alleles, +0.013/y 2 for four or five functioning alleles and +0.090/y 2 for six functioning alleles, P = 0.02) despite similar degrees of pulmonary regurgitation across genotypes early after repair (P = 0.26). At last follow-up, a higher number of functioning HIF1A alleles were also associated with a higher RV fractional area change (EST: +1.2(0.6)% per functioning allele, P = 0.04) (Figure 1b) , lower grade of tricuspid valve regurgitation (EST: −0.066(0.037) per functioning allele, P = 0.07), and lower RV end-systolic area indexed to body size (EST: −0.663(0.287)cm 3 per functioning allele, P = 0.02). There was no association between number of functioning alleles and RV systolic pressure (P = 0.38) or degree of RV hypertrophy (P = 0.29). The overall freedom from RV reinterventions including pulmonary valve or conduit replacement was 92, 84, and 67% at 5, 10, and 15 y, respectively. Freedom from pulmonary valve reinterventions was significantly higher in patients with four or more functioning HIF1A alleles as compared with those with fewer than four functioning HIF1A alleles, with a decrease in hazard ratio for reinterventions by 0.77 for every additional functioning HIF1A allele (P = 0.04) (Figure 2 ).
RV Myocardial Protein Expression and Fibrosis
The expression levels of HIF1A (P = 0.003), VEGF (P = 0.001), and TGFβ1 (P = 0.001) were significantly higher in the RV of 
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Genes and RV remodeling in TOF patients undergoing TOF repair (n = 42, median age 6 mo) as compared with patients undergoing ventricular septal defect repair (n = 20, median age 5.3 mo) (Figure 3) . Fibrosis area was also significantly greater in TOF patients as compared with controls (P < 0.001). Strong red nuclear staining indicated persistent nuclear localization of HIF1A in TOF, suggestive of chronic hypoxia. Representative images are shown in Figure 4 .
We compared RV expression patterns in patients with four or more (n = 30, median age 6 mo) vs. those with fewer than four functioning HIF1A alleles (n = 12, median age 6.4 mo). Patients with four or more functioning alleles had higher nuclear HIF1A expression (P = 0.001) and more fibrosis (P = 0.02) as compared with patients with fewer than four functioning alleles (Figures 3 and 4) . There was a direct correlation between the number of functioning alleles and the intensity of nuclear HIF1A expression (r 2 = 0.45, P = 0.003) and the fibrosis area (r 2 = 0.69, P = 0.005). There was no difference in VEGF expression between genotype groups.
Replication Cohort
Sixty-nine additional eligible TOF patients were genotyped for replication analysis. The replication cohort was comparable to the primary cohort-57% male, 68% white, 19% Asian, . HIF1A genotype and RV protein expression. The relative intensity of protein expression in the RV before repair showed that HIF1A, VEGF, and TGFβ1 expression and fibrosis area were significantly higher in TOF patients with four or more functioning HIF1A alleles undergoing repair (gray) (n = 42) as compared with ventricular septal defect controls undergoing repair (white) (n = 20) (*P < 0.01, **P < 0.001 vs. non-TOF controls). In the TOF cohort, HIF1A expression and fibrosis area were significantly higher in patients with four or more functioning HIF1A alleles (gray) as compared with patients with fewer than four alleles (black) ( †P < 0.05, ‡P < 0.001 vs. TOF with four or more functioning alleles). HIF1A, hypoxia-inducible factor 1α; RV, right-ventricular; TGFB1, transforming growth factor β1; TOF, tetralogy of Fallot; VEGF, vascular endothelial growth factor. Articles Jeewa et al.
7% black, and 6% other. Median age at repair was 0.58 y, and median age at enrollment was 5.4 y. Nineteen precent had an identifiable chromosomal anomaly or syndrome, 9% had a palliative shunt before complete repair, and 25% had a transannular patch repair. Seven patients (10%) underwent pulmonary valve replacement, and four (6%) underwent conduit replacement during follow-up. The frequencies of functioning HIF1A alleles in the replication cohort were comparable to those in the primary cohort: HIF1A145T (rs10873142) 74%, HIF1A1326C (rs2057482) 83%, and HIF1A1744C (rs11549465) 94%. All genotypes were in Hardy-Weinberg equilibrium. Linear regression analysis comparing patients with homozygous HIF1A functioning genotypes to heterozygous or nonfunctioning genotypes revealed a protective effect, with patients homozygous for HIF1A functioning genotypes demonstrating less RV dilation as measured by RV end-diastolic z-score ( Figure 5) . Also, patients with three or more functioning alleles had a lower frequency of RV dysfunction as compared with those with fewer than three functioning alleles (0 vs. 16%, respectively, P < 0.05).
DISCuSSION
Our study identifies HIF1A signaling as an important determinant of myocardial adaptation to hypoxia before repair , and (iii) unrepaired TOF with four or more functioning alleles at complete repair (n = 30). DAPI represents blue nuclear staining. (a) Nuclear HIF1A expression (red) (×600) was stronger in TOF patients with four or more functioning alleles (iii) as compared with controls (i) or TOF patients with fewer than four alleles (ii). (b) Cytoplasmic VEGF expression (red) (×600) was higher in TOF patients as compared with controls but was not significantly different between genotype groups. (c) Cytoplasmic TGFβ1 expression (brown) (×400) was higher in TOF patients with four or more functioning alleles (iii) as compared with controls (i). (d) RV myocardial fibrosis area (blue) (×200) was higher in TOF patients with four or more functioning alleles (iii) as compared with controls (i) or TOF patients with fewer than four alleles (ii). DAPI, 4′,6-diamidino-2-phenylindole; HIF1A, hypoxia-inducible factor 1α; RV, right-ventricular; TGFβ1, transforming-growth factor β1; TOF, tetralogy of Fallot; VEGF, vascular endothelial growth factor; VSD, ventricular septal defect.
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and to RV remodeling during postsurgical follow-up. Genetic variation in the HIF1A gene accounted in part for the interindividual variability in this response. Patients with more HIF1A-functioning alleles had more RV fibrosis at the time of TOF repair but less progression of pulmonary insufficiency, less progression of RV dilation and dysfunction, and greater freedom from RV reinterventions after repair.
HIF1A Genotype and Early RV Phenotype in Unrepaired TOF
Until recently, evaluation of the causes of adverse RV remodeling after TOF repair have focused on anatomic and clinical factors, which have limited sensitivity in predicting which patients are likely to develop progressive RV dilation, dysfunction, and failure and need valve replacement. More recently, the emphasis has shifted to primordial factors that can affect the right ventricle before complete repair, i.e., during the fetal and neonatal periods. Of particular concern is the potential for ongoing hypoxia-and pressure overload-induced injury in the immature right ventricle while awaiting repair. This has led to the adoption of a neonatal repair strategy at several centers in an attempt to protect the RV during this vulnerable period, although the approach has had mixed results (11, 12) . Identifying which patients may truly benefit from early repair has been challenging. Our data show that patients with a higher number of functioning HIF1A alleles had persistent nuclear HIF1A expression, upregulation of the profibrotic cytokine TGFβ1, and RV outflow tract fibrosis in the unrepaired state. The ability to correlate genotype with tissue expression from the same patient is a unique strength of this study and provides biologic support for the observed genetic association. One could argue, on the basis of these findings, that chronic hypoxia and/or mechanical stress in the unrepaired state can have an unfavorable impact on the RV phenotype, especially in patients with HIF1A-upregulation genotypes, and may provide a marker for patients at-risk for injury, who would benefit most from early repair. However, we need to be cautious and should not interpret all fibrosis as detrimental, given that some fibrosis is reversible and may in fact represent a temporary protective phenomenon during adverse environmental conditions such as hypoxia. The protective effect on RV remodeling and function on late follow-up indeed provides some support for the latter hypothesis.
HIF1A Genotype and Late RV Phenotype in Repaired TOF
The second important finding was cardioprotection in the form of slower progression of pulmonary insufficiency, less severe RV dilation on follow-up, and better preservation of RV systolic function in patients with a higher number of functioning HIF1A alleles in both the primary and replication cohorts. Not surprisingly, this was associated with greater freedom from RV reinterventions. Importantly, these associations persisted after correction for race, TOF subtype, age at repair, year of primary repair, type of repair, and duration of follow-up. Although, overall, this RV phenotype would be considered favorable because it delays the need for reinterventions, the susceptibility to fibrosis in the unrepaired state may suggest that the failure to dilate may be related to stiffer ventricles with more fibrosis. In a study of 92 adults, right and left ventricular fibrosis after TOF repair was common and was associated with ventricular dysfunction, exercise intolerance, and clinical arrhythmia (13, 14) . Alternatively, HIF1A signaling may have a true cardioprotective effect through reversible fibroblast transformation of stressed cells during hypoxia in infancy that results in better long-term myocardial adaptation to hemodynamic load. Unfortunately, given the difficulties in detecting myocardial fibrosis noninvasively and the challenges in quantifying diastolic dysfunction by echocardiography, RV fibrosis and diastolic function were not serially assessed during follow-up. Recently, it has become possible to detect regional myocardial fibrosis noninvasively using cardiac magnetic resonance imaging (MRI) with late gadolinium enhancement (13, 14) . A limitation of this technique, however, is that it does not detect early fibrosis, is qualitative, and relies on the difference in signal intensity between normal and scarred myocardium. Although this may be useful in evaluating regional fibrosis in patients with myocardial infarction, it appears to be less sensitive in patients with diffuse interstitial fibrosis (15, 16) . New genetic markers or biomarkers that can identify at-risk patients earlier than current imaging modalities therefore hold promise as risk-stratification tools. In summary, HIF1A is important in the myocardial response to hypoxia before repair and in preserving RV morphology and preventing progressive RV remodeling late after TOF repair. Knowledge of the HIF1A genotype may therefore prove useful in identifying patients who are at risk for progressive RV remodeling after repair and who may benefit from earlier pulmonary valve replacement before the onset of significant RV dilation. Whether this subset of patients may also benefit from early neonatal TOF repair to limit hypoxia-induced RV injury remains to be seen. Our study supports the need for additional genomic studies to identify susceptibility genes that can be used to identify at-risk patients early and intervene before RV remodeling and dysfunction become irreversible. 
